BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9929680)

  • 1. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons.
    Murphy C; Bacon AW; Bondi MW; Salmon DP
    Ann N Y Acad Sci; 1998 Nov; 855():744-50. PubMed ID: 9929680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores.
    Calhoun-Haney R; Murphy C
    Brain Cogn; 2005 Jul; 58(2):178-82. PubMed ID: 15919549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction.
    Bacon AW; Bondi MW; Salmon DP; Murphy C
    Ann N Y Acad Sci; 1998 Nov; 855():723-31. PubMed ID: 9929677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer's Disease.
    Oleson S; Murphy C
    J Alzheimers Dis; 2015; 46(3):791-803. PubMed ID: 25869786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment.
    Wang QS; Tian L; Huang YL; Qin S; He LQ; Zhou JN
    Brain Res; 2002 Sep; 951(1):77-81. PubMed ID: 12231459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature and course of olfactory deficits in Alzheimer's disease.
    Serby M; Larson P; Kalkstein D
    Am J Psychiatry; 1991 Mar; 148(3):357-60. PubMed ID: 1992839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome.
    Sliger M; Lander T; Murphy C
    J Alzheimers Dis; 2004 Aug; 6(4):397-402; discussion 443-9. PubMed ID: 15345810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of olfactory function in dementing disease.
    Murphy C
    Physiol Behav; 1999 Apr; 66(2):177-82. PubMed ID: 10336141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the apolipoprotein E ε4 allele and olfactory function on odor identification networks.
    Frank C; Albertazzi A; Murphy C
    Brain Behav; 2024 May; 14(5):e3524. PubMed ID: 38702902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
    Reijs BLR; Ramakers IHGB; Elias-Sonnenschein L; Teunissen CE; Koel-Simmelink M; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Johannsen P; Vanderstichele H; Verhey F; Devanand DP; Visser PJ
    J Alzheimers Dis; 2017; 60(3):1025-1034. PubMed ID: 28984603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals.
    Olofsson JK; Larsson M; Roa C; Wilson DA; Jonsson Laukka E
    Behav Genet; 2020 Jan; 50(1):3-13. PubMed ID: 31760549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
    Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
    N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls.
    Gilbert PE; Murphy C
    J Clin Exp Neuropsychol; 2004 Sep; 26(6):779-94. PubMed ID: 15370375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of both odor identification and detection deficits in Alzheimer's disease.
    Doty RL; Reyes PF; Gregor T
    Brain Res Bull; 1987 May; 18(5):597-600. PubMed ID: 3607528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia.
    Olofsson JK; Nordin S; Wiens S; Hedner M; Nilsson LG; Larsson M
    Neurobiol Aging; 2010 Apr; 31(4):567-77. PubMed ID: 18619712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease.
    Nordin S; Almkvist O; Berglund B; Wahlund LO
    Arch Neurol; 1997 Aug; 54(8):993-8. PubMed ID: 9267974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.
    Petersen RC; Smith GE; Ivnik RJ; Tangalos EG; Schaid DJ; Thibodeau SN; Kokmen E; Waring SC; Kurland LT
    JAMA; 1995 Apr; 273(16):1274-8. PubMed ID: 7646655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Odor memory in normal aging and Alzheimer's disease.
    Nordin S; Murphy C
    Ann N Y Acad Sci; 1998 Nov; 855():686-93. PubMed ID: 9929672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E polymorphism and Alzheimer's disease.
    Yen YC; Liu CK; Lung FW; Chong MY
    Kaohsiung J Med Sci; 2001 Apr; 17(4):190-7. PubMed ID: 11482130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eyeblink classical conditioning to auditory and olfactory stimuli: performance among older adults with and without the apolipoprotein E epsilon 4 allele.
    Moore AB; Bondi MW; Salmon DP; Murphy C
    Neuropsychology; 2005 Jul; 19(4):437-45. PubMed ID: 16060818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.